45 related articles for article (PubMed ID: 31420297)
21. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.
Blackford AL; Canto MI; Klein AP; Hruban RH; Goggins M
J Natl Cancer Inst; 2020 Nov; 112(11):1162-1169. PubMed ID: 31958122
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.
Gordon-Dseagu VL; Devesa SS; Goggins M; Stolzenberg-Solomon R
Int J Epidemiol; 2018 Apr; 47(2):427-439. PubMed ID: 29149259
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of pancreatic adenocarcinoma.
Simoes PK; Olson SH; Saldia A; Kurtz RC
Chin Clin Oncol; 2017 Jun; 6(3):24. PubMed ID: 28705001
[TBL] [Abstract][Full Text] [Related]
24. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
26. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study.
Gad MM; Saad AM; Al-Husseini MJ; Abdel-Gawad YM; Alsalhani OM; Alhaddad R; Mohamad B; Saleh MA; Simons-Linares CR
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):204-210. PubMed ID: 31420297
[TBL] [Abstract][Full Text] [Related]
27. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.
Eibl G; Cruz-Monserrate Z; Korc M; Petrov MS; Goodarzi MO; Fisher WE; Habtezion A; Lugea A; Pandol SJ; Hart PA; Andersen DK;
J Acad Nutr Diet; 2018 Apr; 118(4):555-567. PubMed ID: 28919082
[TBL] [Abstract][Full Text] [Related]
28. A review of physical activity in pancreatic ductal adenocarcinoma: Epidemiology, intervention, animal models, and clinical trials.
Hsueh HY; Pita-Grisanti V; Gumpper-Fedus K; Lahooti A; Chavez-Tomar M; Schadler K; Cruz-Monserrate Z
Pancreatology; 2022 Jan; 22(1):98-111. PubMed ID: 34750076
[TBL] [Abstract][Full Text] [Related]
29. Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.
Al Haddad AH; Adrian TE
Expert Opin Investig Drugs; 2014 Nov; 23(11):1499-515. PubMed ID: 25078674
[TBL] [Abstract][Full Text] [Related]
30. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
31. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.
Kulkarni NM; Soloff EV; Tolat PP; Sangster GP; Fleming JB; Brook OR; Wang ZJ; Hecht EM; Zins M; Bhosale PR; Arif-Tiwari H; Mannelli L; Kambadakone AR; Tamm EP
Abdom Radiol (NY); 2020 Mar; 45(3):716-728. PubMed ID: 31748823
[TBL] [Abstract][Full Text] [Related]
32. Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years.
Lüttges J; Stigge C; Pacena M; Klöppel G
Cancer; 2004 Jan; 100(1):173-82. PubMed ID: 14692038
[TBL] [Abstract][Full Text] [Related]
33. Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature.
Whitley A; Kocián P; Nikov A; Krejčí D; Pehalová L; Blaha M; Dušek L; Gürlich R
J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1324-1333. PubMed ID: 37750364
[TBL] [Abstract][Full Text] [Related]
34. Burden of Pancreatic Cancer: From Epidemiology to Practice.
Khalaf N; El-Serag HB; Abrams HR; Thrift AP
Clin Gastroenterol Hepatol; 2021 May; 19(5):876-884. PubMed ID: 32147593
[TBL] [Abstract][Full Text] [Related]
35. Reduced risk of pancreatic cancer associated with asthma and nasal allergies.
Gomez-Rubio P; Zock JP; Rava M; Marquez M; Sharp L; Hidalgo M; Carrato A; Ilzarbe L; Michalski C; Molero X; Farré A; Perea J; Greenhalf W; O'Rorke M; Tardón A; Gress T; Barberà V; Crnogorac-Jurcevic T; Domínguez-Muñoz E; Muñoz-Bellvís L; Alvarez-Urturi C; Balcells J; Barneo L; Costello E; Guillén-Ponce C; Kleeff J; Kong B; Lawlor R; Löhr M; Mora J; Murray L; O'Driscoll D; Peláez P; Poves I; Scarpa A; Real FX; Malats N;
Gut; 2017 Feb; 66(2):314-322. PubMed ID: 26628509
[TBL] [Abstract][Full Text] [Related]
36. Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors.
Michalak N; Małecka-Wojciesko E
J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445352
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic cancer: A review of epidemiology, trend, and risk factors.
Hu JX; Zhao CF; Chen WB; Liu QC; Li QW; Lin YY; Gao F
World J Gastroenterol; 2021 Jul; 27(27):4298-4321. PubMed ID: 34366606
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes.
Afghani E; Klein AP
Hematol Oncol Clin North Am; 2022 Oct; 36(5):879-895. PubMed ID: 36154788
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
